ART ∩ SCIENCE ∵ UNMET NEED

Who we are

The partnership was founded to focus on creating successful route-to-market for innovation in beneficial technologies, primarily in the UK's ‘Golden Triangle’ of London, Oxford and Cambridge, and Cambridge, Massachussets in the US. We also have operations elsewhere in the UK and Europe, and in California.

 

  • We support scientists
  • We invest in great inventors
  • We specialise in the development of world-changing innovations to bring them to clinical reality and the benefit of patients. Loxbridge is a powerful new paradigm in health technology commercialisation

 

Loxbridge Press Releases

 

April, 2011: Frost and Sullivan GIL Award, recognising Dr. Charles Roberts - Loxbridge Research CEO

Click here for more information

 

September, 2011: Loxbridge and Dr Kary Mullis Announce the Formation of Altermune Technologies with $7m Seed Investment

Click here for more information
 

Loxbridge is a specialist Venture Pilot ('Project Investment Leveraging Own Teams') company investing in and developing innovative healthcare technologies - please see our ABOUT US page for what is unique about our business model: how we create and support successful Research & Development companies.

What we do

Fund, develop, and perform clinical trials to full ‘proof-of-concept’, select healthcare technologies which:

  • Are ground-breakingly innovative
  • Meet a massive global healthcare need
  • Will deliver both health benefits and ‘progress with profit’

Please see our ACTIVITY AREAS page for more. 

Why

  • We are motivated to generate step-change improvements in the care of the unwell
  • We are driven to advance science
  • We seek to generate and return investment value

>We believe that the right technologies, developed appropriately, should result in a true ‘triple-win’: a success for patients, for science, and for investors

Embracing partnerships

Loxbridge Research projects work collaboratively with groups from the following leading organisations in their field: